nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNA5—artery—uterine cancer	0.0157	0.0437	CbGeAlD
Dalfampridine—KCNG1—myometrium—uterine cancer	0.0119	0.0331	CbGeAlD
Dalfampridine—KCNV1—renal system—uterine cancer	0.0108	0.0299	CbGeAlD
Dalfampridine—Balance disorder—Medroxyprogesterone Acetate—uterine cancer	0.0104	0.0391	CcSEcCtD
Dalfampridine—KCNS2—uterus—uterine cancer	0.0102	0.0284	CbGeAlD
Dalfampridine—KCNG1—uterine cervix—uterine cancer	0.00928	0.0258	CbGeAlD
Dalfampridine—KCNS2—female reproductive system—uterine cancer	0.00917	0.0255	CbGeAlD
Dalfampridine—KCNB1—epithelium—uterine cancer	0.00906	0.0252	CbGeAlD
Dalfampridine—KCNC3—epithelium—uterine cancer	0.0088	0.0245	CbGeAlD
Dalfampridine—KCNB1—smooth muscle tissue—uterine cancer	0.00873	0.0243	CbGeAlD
Dalfampridine—KCNF1—myometrium—uterine cancer	0.0085	0.0236	CbGeAlD
Dalfampridine—KCNS1—epithelium—uterine cancer	0.00814	0.0226	CbGeAlD
Dalfampridine—KCNG1—uterus—uterine cancer	0.00773	0.0215	CbGeAlD
Dalfampridine—KCNS3—myometrium—uterine cancer	0.00744	0.0207	CbGeAlD
Dalfampridine—KCNC4—decidua—uterine cancer	0.00736	0.0205	CbGeAlD
Dalfampridine—KCNF1—uterine cervix—uterine cancer	0.00661	0.0184	CbGeAlD
Dalfampridine—KCNC1—mammalian vulva—uterine cancer	0.00649	0.018	CbGeAlD
Dalfampridine—KCND2—myometrium—uterine cancer	0.00649	0.018	CbGeAlD
Dalfampridine—KCNF1—decidua—uterine cancer	0.0063	0.0175	CbGeAlD
Dalfampridine—KCNG1—vagina—uterine cancer	0.00629	0.0175	CbGeAlD
Dalfampridine—KCNF1—endometrium—uterine cancer	0.00598	0.0166	CbGeAlD
Dalfampridine—KCNA5—uterine cervix—uterine cancer	0.00591	0.0164	CbGeAlD
Dalfampridine—KCNS3—epithelium—uterine cancer	0.00584	0.0162	CbGeAlD
Dalfampridine—KCNS3—uterine cervix—uterine cancer	0.00579	0.0161	CbGeAlD
Dalfampridine—KCND1—female reproductive system—uterine cancer	0.00579	0.0161	CbGeAlD
Dalfampridine—KCNA5—smooth muscle tissue—uterine cancer	0.00575	0.016	CbGeAlD
Dalfampridine—KCNA5—renal system—uterine cancer	0.00553	0.0154	CbGeAlD
Dalfampridine—KCNS1—vagina—uterine cancer	0.00547	0.0152	CbGeAlD
Dalfampridine—KCNS3—renal system—uterine cancer	0.00542	0.0151	CbGeAlD
Dalfampridine—KCNQ5—female reproductive system—uterine cancer	0.00541	0.015	CbGeAlD
Dalfampridine—KCNS3—endometrium—uterine cancer	0.00524	0.0146	CbGeAlD
Dalfampridine—KCND1—vagina—uterine cancer	0.00523	0.0145	CbGeAlD
Dalfampridine—KCNS3—mammalian vulva—uterine cancer	0.00507	0.0141	CbGeAlD
Dalfampridine—KCNH6—renal system—uterine cancer	0.00495	0.0137	CbGeAlD
Dalfampridine—KCNQ5—vagina—uterine cancer	0.00489	0.0136	CbGeAlD
Dalfampridine—KCND2—decidua—uterine cancer	0.00481	0.0134	CbGeAlD
Dalfampridine—KCNF1—vagina—uterine cancer	0.00448	0.0125	CbGeAlD
Dalfampridine—KCNA5—female reproductive system—uterine cancer	0.00443	0.0123	CbGeAlD
Dalfampridine—KCNH6—uterus—uterine cancer	0.00441	0.0122	CbGeAlD
Dalfampridine—KCND3—uterine cervix—uterine cancer	0.0044	0.0122	CbGeAlD
Dalfampridine—KCNQ3—female reproductive system—uterine cancer	0.00434	0.0121	CbGeAlD
Dalfampridine—Infection—Carboplatin—uterine cancer	0.00425	0.0159	CcSEcCtD
Dalfampridine—Nasopharyngitis—Progesterone—uterine cancer	0.00408	0.0153	CcSEcCtD
Dalfampridine—KCNQ1—decidua—uterine cancer	0.00406	0.0113	CbGeAlD
Dalfampridine—KCNA5—female gonad—uterine cancer	0.00403	0.0112	CbGeAlD
Dalfampridine—KCNA5—vagina—uterine cancer	0.00401	0.0111	CbGeAlD
Dalfampridine—KCNQ2—female reproductive system—uterine cancer	0.00399	0.0111	CbGeAlD
Dalfampridine—KCNQ1—renal system—uterine cancer	0.00399	0.0111	CbGeAlD
Dalfampridine—KCNH6—female reproductive system—uterine cancer	0.00396	0.011	CbGeAlD
Dalfampridine—KCNS3—vagina—uterine cancer	0.00392	0.0109	CbGeAlD
Dalfampridine—KCNQ1—mammalian vulva—uterine cancer	0.00373	0.0104	CbGeAlD
Dalfampridine—KCNA3—lymph node—uterine cancer	0.00372	0.0103	CbGeAlD
Dalfampridine—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.0037	0.0139	CcSEcCtD
Dalfampridine—KCND3—uterus—uterine cancer	0.00367	0.0102	CbGeAlD
Dalfampridine—Chest discomfort—Etoposide—uterine cancer	0.00364	0.0136	CcSEcCtD
Dalfampridine—KCNQ2—female gonad—uterine cancer	0.00363	0.0101	CbGeAlD
Dalfampridine—KCNA2—lymph node—uterine cancer	0.00354	0.00984	CbGeAlD
Dalfampridine—Infestation—Progesterone—uterine cancer	0.00352	0.0132	CcSEcCtD
Dalfampridine—Infestation NOS—Progesterone—uterine cancer	0.00352	0.0132	CcSEcCtD
Dalfampridine—KCND2—female gonad—uterine cancer	0.00344	0.00957	CbGeAlD
Dalfampridine—Urinary tract infection—Progesterone—uterine cancer	0.00342	0.0128	CcSEcCtD
Dalfampridine—KCNC4—lymph node—uterine cancer	0.00338	0.00941	CbGeAlD
Dalfampridine—KCNQ1—female reproductive system—uterine cancer	0.00319	0.00887	CbGeAlD
Dalfampridine—Infestation—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.0119	CcSEcCtD
Dalfampridine—Infestation NOS—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.0119	CcSEcCtD
Dalfampridine—KCNQ5—lymph node—uterine cancer	0.00316	0.00879	CbGeAlD
Dalfampridine—Connective tissue disorder—Progesterone—uterine cancer	0.0031	0.0116	CcSEcCtD
Dalfampridine—Urinary tract infection—Medroxyprogesterone Acetate—uterine cancer	0.0031	0.0116	CcSEcCtD
Dalfampridine—KCNQ1—female gonad—uterine cancer	0.0029	0.00808	CbGeAlD
Dalfampridine—Angiopathy—Progesterone—uterine cancer	0.00287	0.0107	CcSEcCtD
Dalfampridine—Immune system disorder—Progesterone—uterine cancer	0.00285	0.0107	CcSEcCtD
Dalfampridine—Mediastinal disorder—Progesterone—uterine cancer	0.00285	0.0107	CcSEcCtD
Dalfampridine—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.00281	0.0105	CcSEcCtD
Dalfampridine—Mental disorder—Progesterone—uterine cancer	0.00277	0.0104	CcSEcCtD
Dalfampridine—Back pain—Progesterone—uterine cancer	0.00266	0.00997	CcSEcCtD
Dalfampridine—KCNG4—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—ABCC9—uterine cancer	0.00261	0.00699	CbGpPWpGaD
Dalfampridine—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.0026	0.00973	CcSEcCtD
Dalfampridine—KCNA5—lymph node—uterine cancer	0.00259	0.00721	CbGeAlD
Dalfampridine—Immune system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00259	0.00969	CcSEcCtD
Dalfampridine—Mediastinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00258	0.00966	CcSEcCtD
Dalfampridine—Tremor—Progesterone—uterine cancer	0.00258	0.00965	CcSEcCtD
Dalfampridine—KCNS3—lymph node—uterine cancer	0.00254	0.00706	CbGeAlD
Dalfampridine—Angioedema—Progesterone—uterine cancer	0.00251	0.00941	CcSEcCtD
Dalfampridine—Mental disorder—Medroxyprogesterone Acetate—uterine cancer	0.00251	0.0094	CcSEcCtD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—CSF3—uterine cancer	0.00243	0.00652	CbGpPWpGaD
Dalfampridine—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00241	0.00903	CcSEcCtD
Dalfampridine—Convulsion—Progesterone—uterine cancer	0.00238	0.00893	CcSEcCtD
Dalfampridine—Chest pain—Progesterone—uterine cancer	0.00234	0.00877	CcSEcCtD
Dalfampridine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.00875	CcSEcCtD
Dalfampridine—Anxiety—Progesterone—uterine cancer	0.00233	0.00874	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.00233	0.00871	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—ABCC9—uterine cancer	0.00232	0.00623	CbGpPWpGaD
Dalfampridine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00228	0.00853	CcSEcCtD
Dalfampridine—Confusional state—Progesterone—uterine cancer	0.00226	0.00848	CcSEcCtD
Dalfampridine—Anaphylactic shock—Progesterone—uterine cancer	0.00224	0.00841	CcSEcCtD
Dalfampridine—Infection—Progesterone—uterine cancer	0.00223	0.00835	CcSEcCtD
Dalfampridine—KCNQ4—Neuronal System—ABCC9—uterine cancer	0.00222	0.00594	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—ABCC9—uterine cancer	0.00222	0.00594	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Progesterone—uterine cancer	0.0022	0.00825	CcSEcCtD
Dalfampridine—Skin disorder—Progesterone—uterine cancer	0.00218	0.00817	CcSEcCtD
Dalfampridine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00216	0.00809	CcSEcCtD
Dalfampridine—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00795	CcSEcCtD
Dalfampridine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00792	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.00211	0.00789	CcSEcCtD
Dalfampridine—Hypotension—Progesterone—uterine cancer	0.0021	0.00786	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—STAR—uterine cancer	0.00209	0.00561	CbGpPWpGaD
Dalfampridine—KCNH2—myometrium—uterine cancer	0.00209	0.0058	CbGeAlD
Dalfampridine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00768	CcSEcCtD
Dalfampridine—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00203	0.00762	CcSEcCtD
Dalfampridine—Insomnia—Progesterone—uterine cancer	0.00203	0.0076	CcSEcCtD
Dalfampridine—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00202	0.00757	CcSEcCtD
Dalfampridine—Paraesthesia—Progesterone—uterine cancer	0.00202	0.00755	CcSEcCtD
Dalfampridine—Dyspnoea—Progesterone—uterine cancer	0.002	0.0075	CcSEcCtD
Dalfampridine—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.00199	0.00747	CcSEcCtD
Dalfampridine—Dyspepsia—Progesterone—uterine cancer	0.00198	0.0074	CcSEcCtD
Dalfampridine—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00198	0.0074	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Progesterone—uterine cancer	0.00194	0.00726	CcSEcCtD
Dalfampridine—KCND3—lymph node—uterine cancer	0.00193	0.00536	CbGeAlD
Dalfampridine—Constipation—Progesterone—uterine cancer	0.00192	0.00719	CcSEcCtD
Dalfampridine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0019	0.00712	CcSEcCtD
Dalfampridine—KCNQ1—lymph node—uterine cancer	0.00187	0.00519	CbGeAlD
Dalfampridine—KCNS3—Neuronal System—ABCC9—uterine cancer	0.00186	0.00498	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—ABCC9—uterine cancer	0.00186	0.00498	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—ABCC9—uterine cancer	0.00186	0.00498	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Progesterone—uterine cancer	0.00185	0.00693	CcSEcCtD
Dalfampridine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00184	0.00689	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—STAR—uterine cancer	0.00183	0.0049	CbGpPWpGaD
Dalfampridine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00183	0.00684	CcSEcCtD
Dalfampridine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00181	0.00679	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—ABCC9—uterine cancer	0.00181	0.00484	CbGpPWpGaD
Dalfampridine—KCNC2—Integration of energy metabolism—STK11—uterine cancer	0.0018	0.00483	CbGpPWpGaD
Dalfampridine—KCNG2—Integration of energy metabolism—STK11—uterine cancer	0.0018	0.00483	CbGpPWpGaD
Dalfampridine—KCNS3—Integration of energy metabolism—STK11—uterine cancer	0.0018	0.00483	CbGpPWpGaD
Dalfampridine—Infestation—Etoposide—uterine cancer	0.0018	0.00674	CcSEcCtD
Dalfampridine—Infestation NOS—Etoposide—uterine cancer	0.0018	0.00674	CcSEcCtD
Dalfampridine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00179	0.00671	CcSEcCtD
Dalfampridine—Urticaria—Progesterone—uterine cancer	0.00178	0.00668	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—ABCC9—uterine cancer	0.00176	0.00472	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.00176	0.00658	CcSEcCtD
Dalfampridine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00174	0.00652	CcSEcCtD
Dalfampridine—KCNB1—Integration of energy metabolism—STK11—uterine cancer	0.00171	0.00458	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—HNF1B—uterine cancer	0.00171	0.00457	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00628	CcSEcCtD
Dalfampridine—Hypersensitivity—Progesterone—uterine cancer	0.00165	0.00619	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—PLXNA3—uterine cancer	0.00165	0.00442	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PLXNA3—uterine cancer	0.00165	0.00442	CbGpPWpGaD
Dalfampridine—KCNH2—uterine cervix—uterine cancer	0.00162	0.00452	CbGeAlD
Dalfampridine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.00605	CcSEcCtD
Dalfampridine—KCNQ1—Neuronal System—ABCC9—uterine cancer	0.00161	0.00432	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—ABCC9—uterine cancer	0.00161	0.00432	CbGpPWpGaD
Dalfampridine—Asthenia—Progesterone—uterine cancer	0.00161	0.00603	CcSEcCtD
Dalfampridine—KCNH6—Neuronal System—ABCC9—uterine cancer	0.00158	0.00423	CbGpPWpGaD
Dalfampridine—Infection—Dactinomycin—uterine cancer	0.00158	0.0059	CcSEcCtD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—YWHAE—uterine cancer	0.00153	0.00409	CbGpPWpGaD
Dalfampridine—KCNH2—renal system—uterine cancer	0.00152	0.00422	CbGeAlD
Dalfampridine—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00561	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—HNF1B—uterine cancer	0.00149	0.004	CbGpPWpGaD
Dalfampridine—Dizziness—Progesterone—uterine cancer	0.00148	0.00556	CcSEcCtD
Dalfampridine—KCNH2—endometrium—uterine cancer	0.00147	0.00408	CbGeAlD
Dalfampridine—Angiopathy—Etoposide—uterine cancer	0.00147	0.00549	CcSEcCtD
Dalfampridine—Immune system disorder—Etoposide—uterine cancer	0.00146	0.00547	CcSEcCtD
Dalfampridine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00547	CcSEcCtD
Dalfampridine—Mediastinal disorder—Etoposide—uterine cancer	0.00146	0.00546	CcSEcCtD
Dalfampridine—KCNA1—Neuronal System—ABCC9—uterine cancer	0.00143	0.00383	CbGpPWpGaD
Dalfampridine—Vomiting—Progesterone—uterine cancer	0.00143	0.00535	CcSEcCtD
Dalfampridine—Rash—Progesterone—uterine cancer	0.00142	0.0053	CcSEcCtD
Dalfampridine—Dermatitis—Progesterone—uterine cancer	0.00141	0.0053	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—ABCC9—uterine cancer	0.00141	0.00377	CbGpPWpGaD
Dalfampridine—Headache—Progesterone—uterine cancer	0.00141	0.00527	CcSEcCtD
Dalfampridine—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—uterine cancer	0.00139	0.00373	CbGpPWpGaD
Dalfampridine—KCNH2—Potassium Channels—ABCC9—uterine cancer	0.00137	0.00366	CbGpPWpGaD
Dalfampridine—Back pain—Etoposide—uterine cancer	0.00136	0.0051	CcSEcCtD
Dalfampridine—KCNH2—uterus—uterine cancer	0.00135	0.00376	CbGeAlD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.00135	0.00361	CbGpPWpGaD
Dalfampridine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00504	CcSEcCtD
Dalfampridine—Nausea—Progesterone—uterine cancer	0.00133	0.00499	CcSEcCtD
Dalfampridine—Feeling abnormal—Dactinomycin—uterine cancer	0.00131	0.0049	CcSEcCtD
Dalfampridine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00484	CcSEcCtD
Dalfampridine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0048	CcSEcCtD
Dalfampridine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.0048	CcSEcCtD
Dalfampridine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00127	0.00477	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.00124	0.00333	CbGpPWpGaD
Dalfampridine—Convulsion—Etoposide—uterine cancer	0.00122	0.00457	CcSEcCtD
Dalfampridine—KCNH2—female reproductive system—uterine cancer	0.00122	0.00338	CbGeAlD
Dalfampridine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00121	0.00453	CcSEcCtD
Dalfampridine—Chest pain—Etoposide—uterine cancer	0.0012	0.00449	CcSEcCtD
Dalfampridine—KCNQ3—Neuronal System—ABCC9—uterine cancer	0.0012	0.00321	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—ABCC9—uterine cancer	0.0012	0.00321	CbGpPWpGaD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.00119	0.00446	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—PLXNA3—uterine cancer	0.00118	0.00315	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PLXNA3—uterine cancer	0.00118	0.00315	CbGpPWpGaD
Dalfampridine—Nasopharyngitis—Epirubicin—uterine cancer	0.00117	0.00439	CcSEcCtD
Dalfampridine—CYP2E1—renal system—uterine cancer	0.00117	0.00325	CbGeAlD
Dalfampridine—Hypersensitivity—Dactinomycin—uterine cancer	0.00117	0.00438	CcSEcCtD
Dalfampridine—Confusional state—Etoposide—uterine cancer	0.00116	0.00434	CcSEcCtD
Dalfampridine—Anaphylactic shock—Etoposide—uterine cancer	0.00115	0.0043	CcSEcCtD
Dalfampridine—Infection—Etoposide—uterine cancer	0.00114	0.00427	CcSEcCtD
Dalfampridine—Asthenia—Dactinomycin—uterine cancer	0.00114	0.00426	CcSEcCtD
Dalfampridine—Skin disorder—Etoposide—uterine cancer	0.00112	0.00418	CcSEcCtD
Dalfampridine—KCNH2—female gonad—uterine cancer	0.00111	0.00308	CbGeAlD
Dalfampridine—KCNH2—vagina—uterine cancer	0.0011	0.00306	CbGeAlD
Dalfampridine—KCND2—Circadian rythm related genes—EZH2—uterine cancer	0.0011	0.00293	CbGpPWpGaD
Dalfampridine—Nasopharyngitis—Doxorubicin—uterine cancer	0.00108	0.00406	CcSEcCtD
Dalfampridine—Hypotension—Etoposide—uterine cancer	0.00107	0.00402	CcSEcCtD
Dalfampridine—Paraesthesia—Etoposide—uterine cancer	0.00103	0.00386	CcSEcCtD
Dalfampridine—Dyspnoea—Etoposide—uterine cancer	0.00102	0.00383	CcSEcCtD
Dalfampridine—Infestation NOS—Epirubicin—uterine cancer	0.00101	0.00378	CcSEcCtD
Dalfampridine—Infestation—Epirubicin—uterine cancer	0.00101	0.00378	CcSEcCtD
Dalfampridine—Vomiting—Dactinomycin—uterine cancer	0.00101	0.00378	CcSEcCtD
Dalfampridine—Rash—Dactinomycin—uterine cancer	0.001	0.00375	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000991	0.00371	CcSEcCtD
Dalfampridine—Constipation—Etoposide—uterine cancer	0.000982	0.00368	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—uterine cancer	0.000981	0.00367	CcSEcCtD
Dalfampridine—KCNH7—Circadian rythm related genes—EZH2—uterine cancer	0.000958	0.00257	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Etoposide—uterine cancer	0.000946	0.00354	CcSEcCtD
Dalfampridine—Nausea—Dactinomycin—uterine cancer	0.000942	0.00353	CcSEcCtD
Dalfampridine—CYP2E1—female reproductive system—uterine cancer	0.000937	0.00261	CbGeAlD
Dalfampridine—Infestation NOS—Doxorubicin—uterine cancer	0.000934	0.0035	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—uterine cancer	0.000934	0.0035	CcSEcCtD
Dalfampridine—Urticaria—Etoposide—uterine cancer	0.000912	0.00342	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—uterine cancer	0.000908	0.0034	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—uterine cancer	0.00089	0.00333	CcSEcCtD
Dalfampridine—Hypersensitivity—Etoposide—uterine cancer	0.000846	0.00317	CcSEcCtD
Dalfampridine—Asthenia—Etoposide—uterine cancer	0.000824	0.00309	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000824	0.00309	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—uterine cancer	0.000822	0.00308	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—uterine cancer	0.000818	0.00307	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—uterine cancer	0.000817	0.00306	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—uterine cancer	0.000794	0.00297	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—uterine cancer	0.000763	0.00286	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—uterine cancer	0.000761	0.00285	CcSEcCtD
Dalfampridine—Dizziness—Etoposide—uterine cancer	0.000759	0.00284	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—uterine cancer	0.000757	0.00284	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000756	0.00283	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—CTNNB1—uterine cancer	0.000745	0.002	CbGpPWpGaD
Dalfampridine—Mental disorder—Doxorubicin—uterine cancer	0.000734	0.00275	CcSEcCtD
Dalfampridine—Vomiting—Etoposide—uterine cancer	0.00073	0.00273	CcSEcCtD
Dalfampridine—Rash—Etoposide—uterine cancer	0.000724	0.00271	CcSEcCtD
Dalfampridine—Dermatitis—Etoposide—uterine cancer	0.000723	0.00271	CcSEcCtD
Dalfampridine—Headache—Etoposide—uterine cancer	0.000719	0.00269	CcSEcCtD
Dalfampridine—KCNH2—lymph node—uterine cancer	0.000712	0.00198	CbGeAlD
Dalfampridine—Back pain—Doxorubicin—uterine cancer	0.000706	0.00264	CcSEcCtD
Dalfampridine—Convulsion—Epirubicin—uterine cancer	0.000683	0.00256	CcSEcCtD
Dalfampridine—Nausea—Etoposide—uterine cancer	0.000682	0.00255	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—uterine cancer	0.000671	0.00251	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—uterine cancer	0.000669	0.00251	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000667	0.0025	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—uterine cancer	0.000649	0.00243	CcSEcCtD
Dalfampridine—KCNS3—Metabolism—SRD5A2—uterine cancer	0.000647	0.00173	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SRD5A2—uterine cancer	0.000647	0.00173	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NDUFB11—uterine cancer	0.000647	0.00173	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SRD5A2—uterine cancer	0.000647	0.00173	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NDUFB11—uterine cancer	0.000647	0.00173	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NDUFB11—uterine cancer	0.000647	0.00173	CbGpPWpGaD
Dalfampridine—Anaphylactic shock—Epirubicin—uterine cancer	0.000644	0.00241	CcSEcCtD
Dalfampridine—Infection—Epirubicin—uterine cancer	0.000639	0.0024	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—uterine cancer	0.000632	0.00237	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—uterine cancer	0.000631	0.00236	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—uterine cancer	0.000625	0.00234	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—uterine cancer	0.000621	0.00233	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—uterine cancer	0.000619	0.00232	CcSEcCtD
Dalfampridine—KCNQ3—Developmental Biology—HNF1B—uterine cancer	0.000618	0.00166	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HNF1B—uterine cancer	0.000618	0.00166	CbGpPWpGaD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000617	0.00231	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—NDUFB11—uterine cancer	0.000614	0.00164	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SRD5A2—uterine cancer	0.000614	0.00164	CbGpPWpGaD
Dalfampridine—Hypotension—Epirubicin—uterine cancer	0.000601	0.00225	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—uterine cancer	0.000601	0.00225	CcSEcCtD
Dalfampridine—KCNH2—Neuronal System—ABCC9—uterine cancer	0.000596	0.0016	CbGpPWpGaD
Dalfampridine—Anaphylactic shock—Doxorubicin—uterine cancer	0.000596	0.00223	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—uterine cancer	0.000592	0.00222	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—uterine cancer	0.000584	0.00219	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—uterine cancer	0.000582	0.00218	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—uterine cancer	0.000579	0.00217	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—uterine cancer	0.000578	0.00216	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—uterine cancer	0.000574	0.00215	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—uterine cancer	0.000567	0.00212	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—uterine cancer	0.000557	0.00208	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000556	0.00208	CcSEcCtD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	0.000552	0.00148	CbGpPWpGaD
Dalfampridine—Constipation—Epirubicin—uterine cancer	0.00055	0.00206	CcSEcCtD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.000545	0.00146	CbGpPWpGaD
Dalfampridine—Insomnia—Doxorubicin—uterine cancer	0.000539	0.00202	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—uterine cancer	0.000535	0.002	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—uterine cancer	0.000531	0.00199	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—uterine cancer	0.00053	0.00199	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000525	0.00141	CbGpPWpGaD
Dalfampridine—Dyspepsia—Doxorubicin—uterine cancer	0.000524	0.00196	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000514	0.00193	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—uterine cancer	0.000511	0.00192	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—uterine cancer	0.000509	0.00191	CcSEcCtD
Dalfampridine—CYP2E1—Tryptophan metabolism—CYP19A1—uterine cancer	0.000503	0.00135	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.000499	0.00134	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Doxorubicin—uterine cancer	0.000491	0.00184	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000484	0.0013	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Epirubicin—uterine cancer	0.000474	0.00178	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—HRAS—uterine cancer	0.000474	0.00127	CbGpPWpGaD
Dalfampridine—Urticaria—Doxorubicin—uterine cancer	0.000473	0.00177	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—AKR1B1—uterine cancer	0.000468	0.00125	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKR1B1—uterine cancer	0.000468	0.00125	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—STAR—uterine cancer	0.000468	0.00125	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKR1B1—uterine cancer	0.000468	0.00125	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—STAR—uterine cancer	0.000468	0.00125	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—STAR—uterine cancer	0.000468	0.00125	CbGpPWpGaD
Dalfampridine—Asthenia—Epirubicin—uterine cancer	0.000462	0.00173	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.00046	0.00123	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—EP300—uterine cancer	0.00045	0.00121	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	0.000448	0.0012	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKR1B1—uterine cancer	0.000444	0.00119	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—STAR—uterine cancer	0.000444	0.00119	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Doxorubicin—uterine cancer	0.000439	0.00164	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—uterine cancer	0.000427	0.0016	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000426	0.00114	CbGpPWpGaD
Dalfampridine—Dizziness—Epirubicin—uterine cancer	0.000426	0.00159	CcSEcCtD
Dalfampridine—CYP2E1—Metapathway biotransformation—AKR1B10—uterine cancer	0.000422	0.00113	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—AKT1—uterine cancer	0.000418	0.00112	CbGpPWpGaD
Dalfampridine—Vomiting—Epirubicin—uterine cancer	0.000409	0.00153	CcSEcCtD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000406	0.00109	CbGpPWpGaD
Dalfampridine—Rash—Epirubicin—uterine cancer	0.000406	0.00152	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—uterine cancer	0.000405	0.00152	CcSEcCtD
Dalfampridine—Headache—Epirubicin—uterine cancer	0.000403	0.00151	CcSEcCtD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000401	0.00107	CbGpPWpGaD
Dalfampridine—Dizziness—Doxorubicin—uterine cancer	0.000394	0.00148	CcSEcCtD
Dalfampridine—CYP2E1—Metapathway biotransformation—AKR1B1—uterine cancer	0.000392	0.00105	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—PTEN—uterine cancer	0.000385	0.00103	CbGpPWpGaD
Dalfampridine—Nausea—Epirubicin—uterine cancer	0.000382	0.00143	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—uterine cancer	0.000379	0.00142	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—uterine cancer	0.000376	0.00141	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—uterine cancer	0.000375	0.00141	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—uterine cancer	0.000373	0.0014	CcSEcCtD
Dalfampridine—KCND2—Circadian rythm related genes—EP300—uterine cancer	0.000368	0.000985	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—POLD1—uterine cancer	0.000367	0.000984	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—POLD1—uterine cancer	0.000367	0.000984	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—POLD1—uterine cancer	0.000367	0.000984	CbGpPWpGaD
Dalfampridine—Nausea—Doxorubicin—uterine cancer	0.000354	0.00133	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—POLD1—uterine cancer	0.000348	0.000933	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKR1C1—uterine cancer	0.000343	0.00092	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKR1C1—uterine cancer	0.000343	0.00092	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKR1C1—uterine cancer	0.000343	0.00092	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—PTEN—uterine cancer	0.000337	0.000903	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000329	0.000883	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKR1C1—uterine cancer	0.000326	0.000872	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—EP300—uterine cancer	0.000321	0.000861	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MET—uterine cancer	0.000314	0.00084	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MET—uterine cancer	0.000314	0.00084	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—HRAS—uterine cancer	0.000313	0.000839	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—RRM2—uterine cancer	0.000306	0.00082	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—RRM2—uterine cancer	0.000306	0.00082	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—RRM2—uterine cancer	0.000306	0.00082	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—DCN—uterine cancer	0.000297	0.000796	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—DCN—uterine cancer	0.000297	0.000796	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—DCN—uterine cancer	0.000297	0.000796	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—RRM2—uterine cancer	0.00029	0.000777	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—AKR1C1—uterine cancer	0.000288	0.000771	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—DCN—uterine cancer	0.000282	0.000755	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP11A1—uterine cancer	0.00028	0.00075	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP11A1—uterine cancer	0.00028	0.00075	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP11A1—uterine cancer	0.00028	0.00075	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—HRAS—uterine cancer	0.000279	0.000748	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SMAD3—uterine cancer	0.000273	0.000732	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SMAD3—uterine cancer	0.000273	0.000732	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—uterine cancer	0.000266	0.000714	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—uterine cancer	0.000266	0.000714	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP11A1—uterine cancer	0.000265	0.000711	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKR1C3—uterine cancer	0.000264	0.000708	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKR1C3—uterine cancer	0.000264	0.000708	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKR1C3—uterine cancer	0.000264	0.000708	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—uterine cancer	0.000263	0.000705	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.000253	0.000677	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKR1C3—uterine cancer	0.000251	0.000672	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	0.000238	0.000637	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000235	0.000629	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—uterine cancer	0.00023	0.000616	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—uterine cancer	0.000229	0.000614	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—uterine cancer	0.000229	0.000614	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—uterine cancer	0.000224	0.0006	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—uterine cancer	0.000224	0.0006	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—uterine cancer	0.000223	0.000598	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—uterine cancer	0.000223	0.000598	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—uterine cancer	0.000223	0.000598	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	0.000222	0.000594	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—uterine cancer	0.000217	0.000582	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—uterine cancer	0.000212	0.000567	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—STK11—uterine cancer	0.000206	0.000552	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP19A1—uterine cancer	0.000206	0.000552	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—STK11—uterine cancer	0.000206	0.000552	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—STK11—uterine cancer	0.000206	0.000552	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP19A1—uterine cancer	0.000206	0.000552	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP19A1—uterine cancer	0.000206	0.000552	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP19A1—uterine cancer	0.000195	0.000523	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—STK11—uterine cancer	0.000195	0.000523	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000194	0.000521	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—uterine cancer	0.000194	0.000518	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—uterine cancer	0.000194	0.000518	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—uterine cancer	0.00019	0.000508	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000179	0.00048	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—uterine cancer	0.000177	0.000473	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—uterine cancer	0.000177	0.000473	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	0.000175	0.000469	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—uterine cancer	0.000174	0.000467	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—uterine cancer	0.000174	0.000467	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	0.000173	0.000462	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—uterine cancer	0.000172	0.00046	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—uterine cancer	0.000169	0.000453	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000167	0.000446	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—uterine cancer	0.000164	0.000438	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—uterine cancer	0.000164	0.000438	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000158	0.000423	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—uterine cancer	0.000155	0.000415	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—uterine cancer	0.000155	0.000415	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—uterine cancer	0.000155	0.000415	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—uterine cancer	0.00015	0.000402	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—uterine cancer	0.00015	0.000402	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—uterine cancer	0.000147	0.000393	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—uterine cancer	0.000144	0.000385	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—uterine cancer	0.000144	0.000385	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CTNNB1—uterine cancer	0.000143	0.000384	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CTNNB1—uterine cancer	0.000143	0.000384	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EP300—uterine cancer	0.000133	0.000356	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EP300—uterine cancer	0.000133	0.000356	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—uterine cancer	0.000128	0.000342	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—uterine cancer	0.000128	0.000342	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—uterine cancer	0.000126	0.000338	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—uterine cancer	0.000126	0.000338	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—uterine cancer	0.000124	0.000333	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—uterine cancer	0.000124	0.000333	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—uterine cancer	0.000107	0.000287	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—uterine cancer	0.000107	0.000287	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NDUFB11—uterine cancer	9.4e-05	0.000252	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SRD5A2—uterine cancer	9.4e-05	0.000252	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—uterine cancer	9.11e-05	0.000244	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—uterine cancer	9.11e-05	0.000244	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—uterine cancer	8.61e-05	0.000231	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—uterine cancer	8.61e-05	0.000231	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—uterine cancer	8.61e-05	0.000231	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—EP300—uterine cancer	8.21e-05	0.00022	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—EP300—uterine cancer	8.21e-05	0.00022	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—EP300—uterine cancer	8.21e-05	0.00022	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—uterine cancer	8.16e-05	0.000219	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—uterine cancer	8.04e-05	0.000215	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—uterine cancer	8.04e-05	0.000215	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—EP300—uterine cancer	7.79e-05	0.000209	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—uterine cancer	7.16e-05	0.000192	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STAR—uterine cancer	6.8e-05	0.000182	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1B1—uterine cancer	6.8e-05	0.000182	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—uterine cancer	6.08e-05	0.000163	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—uterine cancer	6.08e-05	0.000163	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—uterine cancer	6.08e-05	0.000163	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—uterine cancer	5.76e-05	0.000154	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—POLD1—uterine cancer	5.34e-05	0.000143	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C1—uterine cancer	4.99e-05	0.000134	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—uterine cancer	4.96e-05	0.000133	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—uterine cancer	4.96e-05	0.000133	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—uterine cancer	4.96e-05	0.000133	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—uterine cancer	4.71e-05	0.000126	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RRM2—uterine cancer	4.45e-05	0.000119	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DCN—uterine cancer	4.32e-05	0.000116	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP11A1—uterine cancer	4.07e-05	0.000109	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C3—uterine cancer	3.84e-05	0.000103	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP19A1—uterine cancer	2.99e-05	8.02e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STK11—uterine cancer	2.99e-05	8.02e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—uterine cancer	2.25e-05	6.03e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—uterine cancer	1.25e-05	3.35e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—EP300—uterine cancer	1.19e-05	3.2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—uterine cancer	8.83e-06	2.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—uterine cancer	7.21e-06	1.93e-05	CbGpPWpGaD
